Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON31321Phase 3Not yet recruiting
Phase 3, open-label trial of atorvastatin in Coarctation of the aorta (CoA) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Change in carotid intima-media thickness. Planned start Sep 2007; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON31321.